{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:47:42Z","timestamp":1774918062150,"version":"3.50.1"},"reference-count":66,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Canadian Network on Hepatitis C (CanHepC)","award":["NHC-142832"],"award-info":[{"award-number":["NHC-142832"]}]},{"name":"Canadian Network on Hepatitis C (CanHepC)","award":["NHE-174228"],"award-info":[{"award-number":["NHE-174228"]}]},{"name":"Canadian Network on Hepatitis C (CanHepC)","award":["HPC-178912"],"award-info":[{"award-number":["HPC-178912"]}]},{"name":"career award from the Fonds de Recherche Qu\u00e9bec\u2014Sant\u00e9 (FRQS; Junior 1)","award":["NHC-142832"],"award-info":[{"award-number":["NHC-142832"]}]},{"name":"career award from the Fonds de Recherche Qu\u00e9bec\u2014Sant\u00e9 (FRQS; Junior 1)","award":["NHE-174228"],"award-info":[{"award-number":["NHE-174228"]}]},{"name":"career award from the Fonds de Recherche Qu\u00e9bec\u2014Sant\u00e9 (FRQS; Junior 1)","award":["HPC-178912"],"award-info":[{"award-number":["HPC-178912"]}]},{"name":"career award (FRQ-S; Junior 2)","award":["NHC-142832"],"award-info":[{"award-number":["NHC-142832"]}]},{"name":"career award (FRQ-S; Junior 2)","award":["NHE-174228"],"award-info":[{"award-number":["NHE-174228"]}]},{"name":"career award (FRQ-S; Junior 2)","award":["HPC-178912"],"award-info":[{"award-number":["HPC-178912"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Hepatitis C virus (HCV) disproportionately affects certain sub-populations, including people with experience of incarceration (PWEI). Little is known about how perceptions of HCV and treatment have changed despite simplifications in testing and treatment in carceral settings. Nineteen semi-structured interviews were conducted with people living with or having a history of HCV infection released from Quebec provincial prison. Interviews were guided by the Common Sense Self-Regulation Model (CS-SRM) and aimed to explore cognitive and emotional representations of HCV and coping strategies. Among the 19 participants, seven (37%) were diagnosed with HCV in prison and 14 (74%) had previously received HCV treatment. Participants\u2019 HCV illness perceptions were influenced by fear (of HCV transmission, death, and the well-being of family) and stigma (related to HCV, injection drug use, and incarceration). While some sought education and social and professional support, others self-isolated or engaged in high-risk behaviors to cope. Despite advances in HCV treatment, PWEI continue to experience various forms of stigma and fear surrounding their HCV diagnosis, resulting in delayed HCV care. These findings provide insights into how prison-based healthcare providers can better utilize HCV illness perceptions to evaluate willingness to engage in HCV care among PWEI.<\/jats:p>","DOI":"10.3390\/v16121910","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T03:52:49Z","timestamp":1733975569000},"page":"1910","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Understanding Perceptions of Hepatitis C and Its Management Among People with Experience of Incarceration in Quebec, Canada: A Qualitative Study Guided by the Common Sense Self-Regulation Model"],"prefix":"10.3390","volume":"16","author":[{"given":"Andrea","family":"Mambro","sequence":"first","affiliation":[{"name":"Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7777-0474","authenticated-orcid":false,"given":"Sameh","family":"Mortazhejri","sequence":"additional","affiliation":[{"name":"Centre for Implementation Research, Methodological and Implementation Research, Ottawa Hospital Research Institute, Ottawa, Canada"},{"name":"School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0431-4889","authenticated-orcid":false,"given":"David","family":"Ortiz-Paredes","sequence":"additional","affiliation":[{"name":"Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Patey","sequence":"additional","affiliation":[{"name":"Centre for Implementation Research, Methodological and Implementation Research, Ottawa Hospital Research Institute, Ottawa, Canada"},{"name":"School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada"},{"name":"School of Rehabilitation Therapy, Queen\u2019s University, Kingston, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7806-814X","authenticated-orcid":false,"given":"Guillaume","family":"Fontaine","sequence":"additional","affiliation":[{"name":"Centre for Implementation Research, Methodological and Implementation Research, Ottawa Hospital Research Institute, Ottawa, Canada"},{"name":"Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada"},{"name":"Ingram School of Nursing, Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada"},{"name":"Kirby Institute, University of New South Wales, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Dussault","sequence":"additional","affiliation":[{"name":"Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Cox","sequence":"additional","affiliation":[{"name":"Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Canada"},{"name":"Department of Medicine, Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre, Montreal, Canada"},{"name":"Department of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy M.","family":"Grimshaw","sequence":"additional","affiliation":[{"name":"Centre for Implementation Research, Methodological and Implementation Research, Ottawa Hospital Research Institute, Ottawa, Canada"},{"name":"School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada"},{"name":"Department of Medicine, University of Ottawa, Ottawa, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Presseau","sequence":"additional","affiliation":[{"name":"Centre for Implementation Research, Methodological and Implementation Research, Ottawa Hospital Research Institute, Ottawa, Canada"},{"name":"School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada"},{"name":"School of Psychology, University of Ottawa, Ottawa, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2724-0496","authenticated-orcid":false,"given":"Nadine","family":"Kronfli","sequence":"additional","affiliation":[{"name":"Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Canada"},{"name":"Department of Medicine, Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre, Montreal, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2024, July 09). Combating Hepatitis B and C to Reach Elimination by 2030. Advocacy Brief, 2016. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/206453\/WHO_HIV_2016.04_eng.pdf?sequence=1."},{"key":"ref_2","unstructured":"World Health Organization (2024, July 09). Global Health Sector Strategy on Viral Hepatitis 2016\u20132021: Towards Ending Viral Hepatitis. World Health Organization, 2016. Available online: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/246177\/WHO-HIV-2016.06-eng.pdf."},{"key":"ref_3","unstructured":"Canadian Network on Hepatitis C (2024, July 09). Blueprint to Inform Hepatitis C Elimination Efforts in Canada, 2019. Available online: https:\/\/www.canhepc.ca\/sites\/default\/files\/media\/documents\/blueprint_hcv_2019_05.pdf."},{"key":"ref_4","unstructured":"Public Health Agency of Canada (2024, July 09). People living with Hepatitis C (HCV) in Canada\u2014Canada.ca. Government of Canada, 2022. Available online: https:\/\/canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/infographic-people-living-with-hepatitis-c.html."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"E93","DOI":"10.1503\/cmaj.171142","article-title":"Care for people with hepatitis C in provincial and territorial prisons","volume":"190","author":"Kronfli","year":"2018","journal-title":"CMAJ Can. Med. Assoc. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugpo.2018.04.003","article-title":"Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: A systematic review","volume":"57","author":"Kronfli","year":"2018","journal-title":"Int. J. Drug Policy"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3138\/canlivj.2019-0007","article-title":"The elimination of hepatitis C virus (HCV) in Canadian correctional facilities: Where are we and where do we need to be?","volume":"2","author":"Kronfli","year":"2019","journal-title":"Can. Liver J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"102921","DOI":"10.1016\/j.drugpo.2020.102921","article-title":"A randomized pilot study assessing the acceptability of rapid point-of-care hepatitis C virus (HCV) testing among male inmates in Montreal, Canada","volume":"85","author":"Kronfli","year":"2020","journal-title":"Int. J. Drug Policy"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3138\/canlivj-2020-0035","article-title":"Disparities in hepatitis C care across Canadian provincial prisons: Implications for hepatitis C micro-elimination","volume":"4","author":"Kronfli","year":"2021","journal-title":"Can. Liver J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"104386","DOI":"10.1016\/j.drugpo.2024.104386","article-title":"Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit","volume":"126","author":"Walker","year":"2024","journal-title":"Int. J. Drug Policy"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3138\/canlivj-2022-0040","article-title":"Public reimbursement policies in Canada for direct-acting antiviral treatment of hepatitis C virus infection: A descriptive study","volume":"6","author":"Snell","year":"2023","journal-title":"Can. Liver J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S2468-1253(20)30365-4","article-title":"Hepatitis C elimination among people incarcerated in prisons: Challenges and recommendations for action within a Health Systems Framework","volume":"6","author":"Akiyama","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e578","DOI":"10.1016\/S2468-2667(22)00119-0","article-title":"The role of low-income and middle-income country prisons in eliminating hepatitis C","volume":"7","author":"Akiyama","year":"2022","journal-title":"Lancet Public Health"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/08870446.2015.1012195","article-title":"The hepatitis C treatment experience: Patients\u2019 perceptions of the facilitators of and barriers to uptake, adherence and completion","volume":"30","author":"Sublette","year":"2015","journal-title":"Psychol. Health"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.drugpo.2013.11.004","article-title":"Views and experiences of hepatitis C testing and diagnosis among people who inject drugs: Systematic review of qualitative research","volume":"25","author":"Jones","year":"2014","journal-title":"Int. J. Drug Policy"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.socscimed.2004.02.021","article-title":"Preventing hepatitis C: \u2018common sense\u2019, \u2018the bug\u2019 and other perspectives from the risk narratives of people who inject drugs","volume":"59","author":"Davis","year":"2004","journal-title":"Soc. Sci. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/j.1360-0443.2008.02306.x","article-title":"The social production of hepatitis C risk among injecting drug users: A qualitative synthesis","volume":"103","author":"Rhodes","year":"2008","journal-title":"Addiction"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12954-015-0054-1","article-title":"The common sense model applied to hepatitis C: A qualitative analysis of the impact of disease comparison and witnessed death on hepatitis C illness perception","volume":"12","author":"Safo","year":"2015","journal-title":"Harm Reduct. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12954-024-01009-7","article-title":"Barriers to access to hepatitis C treatment with direct-acting antivirals in people who inject drugs in the community setting","volume":"21","author":"Yela","year":"2024","journal-title":"Harm Reduct. J."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Yap, L., Carruthers, S., Thompson, S., Cheng, W., Jones, J., Simpson, P., Richards, A., Thein, H., Haber, P., and Lloyd, A. (2014). A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0087564"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Khaw, F., Stobbart, L., and Murtagh, M.J. (2007). \u2018I just keep thinking I haven\u2019t got it because I\u2019m not yellow\u2019: A qualitative study of the factors that influence the uptake of Hepatitis C testing by prisoners. BMC Public Health, 7.","DOI":"10.1186\/1471-2458-7-98"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"762","DOI":"10.7326\/0003-4819-144-10-200605160-00010","article-title":"A framework for management of hepatitis C in prisons","volume":"144","author":"Spaulding","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12954-021-00494-4","article-title":"Considering treatment-as-prevention scale-up for Australian prisons: A qualitative sub-study of expert stakeholders from the Australian \u2018surveillance and treatment of prisoners with hepatitis C\u2019 project (SToP-C)","volume":"18","author":"Rance","year":"2021","journal-title":"Harm Reduct. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12954-018-0269-z","article-title":"Barriers and facilitators to hepatitis C (HCV) screening and treatment-a description of prisoners perspective","volume":"15","author":"Crowley","year":"2018","journal-title":"Harm Reduct. J."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Crowley, D., Cullen, W., Lambert, J.S., and Van Hout, M.C. (2019). Competing priorities and second chances\u2014A qualitative exploration of prisoners\u2019 journeys through the Hepatitis C continuum of care. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0222186"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF01173486","article-title":"Illness cognition: Using common sense to understand treatment adherence and affect cognition interactions","volume":"16","author":"Leventhal","year":"1992","journal-title":"Cogn. Ther. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12160-010-9246-9","article-title":"Cognitive science speaks to the \u201ccommon-sense\u201d of chronic illness management","volume":"41","author":"Leventhal","year":"2011","journal-title":"Ann. Behav. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/rheumatology\/kem060","article-title":"The common-sense model of self-regulation of health and illness: How can we use it to understand and respond to our patients\u2019 needs?","volume":"46","author":"Hale","year":"2007","journal-title":"Rheumatology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/17437199.2021.1878050","article-title":"The common sense model of illness self-regulation: A conceptual review and proposed extended model","volume":"16","author":"Hagger","year":"2021","journal-title":"Health Psychol. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"103320","DOI":"10.1016\/j.drugpo.2021.103320","article-title":"Conceptualising hepatitis C stigma: A thematic synthesis of qualitative research","volume":"96","author":"Harris","year":"2021","journal-title":"Int. J. Drug Policy"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000019005","article-title":"Drug injectors and the cleaning of needles and syringes","volume":"6","author":"Hughes","year":"2000","journal-title":"Eur. Addict. Res."},{"key":"ref_32","first-page":"448","article-title":"and Hepatitis C Incidence and Transmission in Prisons Study group. Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study cohort, Australia","volume":"81","author":"Gates","year":"2004","journal-title":"J. Urban Health Bull. N. Y. Acad. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2524.2005.00552.x","article-title":"Exploring risk perception and behaviour of homeless injecting drug users diagnosed with hepatitis C","volume":"13","author":"Wright","year":"2005","journal-title":"Health Soc. Care Community"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"103456","DOI":"10.1016\/j.drugpo.2021.103456","article-title":"\u201cThat was quick, simple, and easy\u201d: Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison","volume":"99","author":"Lafferty","year":"2022","journal-title":"Int. J. Drug Policy"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1080\/09687637.2018.1494135","article-title":"\u2018Fighting a losing battle\u2019: Prisoners\u2019 perspectives of treatment as prevention for hepatitis C with inadequate primary prevention measures","volume":"26","author":"Lafferty","year":"2018","journal-title":"Drugs Educ. Prev. Policy"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"102693","DOI":"10.1016\/j.drugpo.2020.102693","article-title":"Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting","volume":"77","author":"Lafferty","year":"2020","journal-title":"Int. J. Drug Policy"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1363459316660859","article-title":"Practices of partnership: Negotiated safety among couples who inject drugs","volume":"22","author":"Rance","year":"2018","journal-title":"Health"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1111\/j.1360-0443.2006.01617.x","article-title":"Drug injecting and syringe use in the HIV risk environment of Russian penitentiary institutions: Qualitative study","volume":"101","author":"Sarang","year":"2006","journal-title":"Addiction"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/QAI.0b013e31821e9f41","article-title":"HIV risk after release from prison: A qualitative study of former inmates","volume":"57","author":"Adams","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12954-018-0246-6","article-title":"A policy analysis exploring hepatitis C risk, prevention, testing, treatment and reinfection within Australia\u2019s prisons","volume":"15","author":"Lafferty","year":"2018","journal-title":"Harm Reduct. J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"103837","DOI":"10.1016\/j.drugpo.2022.103837","article-title":"Identifying barriers and enablers to opt-out hepatitis C virus screening in provincial prisons in Quebec, Canada: A multilevel, multi-theory informed qualitative study with correctional and healthcare professional stakeholders","volume":"109","author":"Ruiz","year":"2022","journal-title":"Int. J. Drug Policy"},{"key":"ref_42","unstructured":"Statistics Canada (2024, July 15). Table: 35-10-0154-01. Average Counts of Adults in Provincial and Territorial Correctional Programs, 2024. Available online: https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=3510015401&pickMembers%5B0%5D=1.6&cubeTimeFrame.startYear=2018+%2F+2019&cubeTimeFrame.endYear=2022+%2F+2023&referencePeriods=20180101%2C20220101."},{"key":"ref_43","unstructured":"Malakieh, J. (2024, July 15). Adult and youth correctional statistics in Canada, 2018\/2019, 2020. Available online: https:\/\/www150.statcan.gc.ca\/n1\/pub\/85-002-x\/2020001\/article\/00016-eng.htm."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Kronfli, N., Dussault, C., Maheu-Giroux, M., Halavrezos, A., Chalifoux, S., Park, H., Balso, L.D., Cheng, M.P., and Cox, J. (2022). Importance of occupation for SARS-CoV-2 seroprevalence and COVID-19 vaccination among correctional workers in Quebec, Canada: A cross-sectional study. Front. Public Health, 10.","DOI":"10.3389\/fpubh.2022.1021871"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1093\/cid\/ciac031","article-title":"Seroprevalence and Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 Among Incarcerated Adult Men in Quebec, Canada, 2021","volume":"75","author":"Kronfli","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"104124","DOI":"10.1016\/j.drugpo.2023.104124","article-title":"\u201cApparently, you can only be treated once\u201d: A qualitative study exploring perceptions of hepatitis C and access to treatment among people who inject drugs visiting a needle and syringe program","volume":"121","author":"Fontaine","year":"2023","journal-title":"Int. J. Drug Policy"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1080\/08870440903194015","article-title":"What is an adequate sample size? Operationalising data saturation for theory-based interview studies","volume":"25","author":"Francis","year":"2009","journal-title":"Psychol. Health"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"104283","DOI":"10.1016\/j.drugpo.2023.104283","article-title":"Reimbursing incarcerated individuals for participation in research: A scoping review","volume":"123","author":"Mambro","year":"2024","journal-title":"Int. J. Drug Policy"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3350\/cmh.2022.0349","article-title":"Acute hepatitis C virus infection: Clinical update and remaining challenges","volume":"29","author":"Liu","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61","author":"Westbrook","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Zaltron, S., Spinetti, A., Biasi, L., Baiguera, C., and Castelli, F. (2012). Chronic HCV infection: Epidemiological and clinical relevance. BMC Infect. Dis., 12.","DOI":"10.1186\/1471-2334-12-S2-S2"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12954-020-00399-8","article-title":"\u201cThey look at us like junkies\u201d: Influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City","volume":"17","author":"Muncan","year":"2020","journal-title":"Harm Reduct. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s10461-013-0437-9","article-title":"HIV stigma mechanisms and well-being among PLWH: A test of the HIV stigma framework","volume":"17","author":"Earnshaw","year":"2013","journal-title":"AIDS Behav."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40352-016-0040-z","article-title":"Unlocking dimensions of social capital in the prison setting","volume":"4","author":"Lafferty","year":"2016","journal-title":"Health Justice"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/00343400500328222","article-title":"Measuring community strength and social capital","volume":"39","author":"Western","year":"2005","journal-title":"Reg. Stud."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s11186-008-9062-4","article-title":"Social exclusion and social capital: A comparison and critique","volume":"37","author":"Daly","year":"2008","journal-title":"Theory Soc."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s40271-020-00489-6","article-title":"Patient Centeredness in Hepatitis C Direct-Acting Antiviral Treatment Delivery to People Who Inject Drugs: A Scoping Review","volume":"14","author":"Abdelwadoud","year":"2021","journal-title":"Patient"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jhep.2023.04.019","article-title":"A \u201cone-stop-shop\u201d point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study","volume":"79","author":"Sheehan","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.vaccine.2023.01.040","article-title":"Education increases COVID-19 vaccine uptake among people in Canadian federal prisons in a prospective randomized controlled trial: The EDUCATE study","volume":"41","author":"Zolotarova","year":"2023","journal-title":"Vaccine"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"104516","DOI":"10.1016\/j.drugpo.2024.104516","article-title":"Understanding hepatitis C virus (HCV) health literacy and educational needs among people in prison to enhance HCV care in prisons","volume":"130","author":"Sheehan","year":"2024","journal-title":"Int. J. Drug Policy"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"104461","DOI":"10.1016\/j.drugpo.2024.104461","article-title":"Development of an evidence-based hepatitis C education program to enhance public health literacy in the Australian prison sector: The Hepatitis in Prisons Education program (HepPEd)","volume":"129","author":"Sheehan","year":"2024","journal-title":"Int. J. Drug Policy"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5694\/mja2.51854","article-title":"Consensus recommendations on the management of hepatitis C in Australia\u2019s prisons","volume":"218","author":"Winter","year":"2023","journal-title":"Med. J. Aust."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Bagnall, A.M., South, J., Hulme, C., Woodall, J., Vinall-Collier, K., Raine, G., Kinsella, K., Dixey, R., Harris, L., and Wright, N.M.J. (2015). A systematic review of the effectiveness and cost--effectiveness of peer education and peer support in prisons. BMC Public Health, 15.","DOI":"10.1186\/s12889-015-1584-x"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12954-019-0313-7","article-title":"Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners","volume":"16","author":"Crowley","year":"2019","journal-title":"Harm Reduct. J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1177\/0032885517728901","article-title":"Insights on Prison Needle and Syringe Programs: Research With Former Prisoners in Canada","volume":"97","author":"Watson","year":"2017","journal-title":"Prison J."},{"key":"ref_66","first-page":"91","article-title":"Coping strategies in hepatitis C patients during the course of antiviral treatment of HCV","volume":"18","author":"Hassan","year":"2021","journal-title":"PalArch\u2019s J. Vertebr. Palaeontol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/12\/1910\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:53:15Z","timestamp":1760115195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/12\/1910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":66,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["v16121910"],"URL":"https:\/\/doi.org\/10.3390\/v16121910","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,12]]}}}